MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1043.15%
Quick Ratio
1043.15%
Cash Ratio
1013.20%
Debt to Asset Ratio
10.65%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Restricted cash, non-current
    • Other non-current assets
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Other current liabilities
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
329,462 307,531 330,843 371,435
Prepaid expenses and other current assets
9,739 7,662 9,131 14,040
Total current assets
339,201 315,193 339,974 385,475
Property and equipment, net
1,960 2,144 2,463 2,690
Operating lease right-of-use assets
7,391 8,125 8,849 9,563
Deferred tax assets
NaN 0 0 0
Restricted cash, non-current
860 860 860 860
Other non-current assets
482 482 482 478
Total non-current assets
10,693 11,611 12,654 13,591
Total assets
349,894 326,804 352,628 399,066
Accounts payable
4,299 5,875 10,503 12,198
Accrued research and development
4,611 4,329 9,544 10,929
Deferred revenue, current
1,630 2,664 2,685 5,100
Restructuring liability
8,585 13,303 17,614 30,330
Lease liability, current
2,893 2,886 2,879 2,853
Other current liabilities
10,499 11,786 8,211 6,397
Total current liabilities
32,517 40,843 51,436 67,807
Deferred revenue, non-current
NaN 0 0 0
Lease liability, non-current
4,761 5,487 6,203 6,928
Total non-current liabilities
4,761 5,487 6,203 6,928
Total liabilities
37,278 46,330 57,639 74,735
Euro deferred shares, 22 nominal value authorized shares 10,000 at march31, 2026 and december31, 2025 issued and outstanding shares none at march31, 2026 and december31, 2025
0 0 0 0
Ordinary shares, 0.01 par value authorized shares 100,000,000 at march31, 2026 and december31, 2025. issued and outstanding shares 53,077,225 and 53,832,982 at march31, 2026 and december31, 2025, respectively
530 538 538 538
Additional paid-in capital
1,625,798 1,626,369 1,619,295 1,612,096
Accumulated deficit
-1,313,712 -1,346,433 -1,324,844 -1,288,303
Total shareholders equity
312,616 280,474 294,989 324,331
Total liabilities and shareholders equity
349,894 326,804 352,628 399,066
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$329,462K Prepaid expenses andother current assets$9,739K Operating leaseright-of-use assets$7,391K Property and equipment,net$1,960K Restricted cash,non-current$860K Other non-currentassets$482K Total current assets$339,201K Total non-currentassets$10,693K Total assets$349,894K Total liabilities andshareholders equity$349,894K Total shareholdersequity$312,616K Total liabilities$37,278K Accumulated deficit-$1,313,712K Additional paid-in capital$1,625,798K Total currentliabilities$32,517K Total non-currentliabilities$4,761K Ordinary shares, 0.01 parvalue authorized...$530K Other currentliabilities$10,499K Restructuring liability$8,585K Accrued research anddevelopment$4,611K Accounts payable$4,299K Lease liability,current$2,893K Deferred revenue,current$1,630K Lease liability,non-current$4,761K

PROTHENA CORP PUBLIC LTD CO (PRTA)

PROTHENA CORP PUBLIC LTD CO (PRTA)